Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 5, 2021
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
[ Fri, Mar 05th 2021
] - WOPRAI
Carter Gould Maintained (AMGN) at Hold with Decreased Target to $230 on, Mar 5th, 2021
Carter Gould of Barclays, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $242 to $230 on, Mar 5th, 2021.
Carter has made no other calls on AMGN in the last 4 months.
There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 0 agree with Carter's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Carter
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $295 on, Wednesday, February 3rd, 2021
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $260 on, Wednesday, February 3rd, 2021
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $265 on, Wednesday, February 3rd, 2021
